Humanized monoclonal antibodies targeting hypoxic human tumors via two distinct extracellular domains of carbonic anhydrase IX. Hypoxia of the tumor microenvironment (TME) is often the main factor in the development of cancer. Also, low oxygen levels in tumor tissues may indicate that first or second line treatment will not be successful. This knowledge leads to…